• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Innovate U.K., Medical Research Council award $47.1M

Innovate U.K., Medical Research Council award $47.1M

November 24, 2014
CenterWatch Staff

Innovate U.K. and the Medical Research Council have awarded over $47.1 million in new funding through the Biomedical Catalyst, part of the U.K. government’s life sciences strategy.

Twenty-nine companies and universities in the U.K. now have funding to tackle healthcare challenges ranging from cancer to childbirth complications. Projects supported include:

  • pH paper to prevent fatality through incorrect placement of feeding tubes
  • dressings with embedded clotting agents, which can be left in the body
  • ozone-based generator to decontaminate medical equipment
  • drugs to reduce swelling and pain caused by rheumatoid arthritis
  • a sensor hat to monitor newborn babies requiring resuscitation
  • new gene therapy to tackle nerve and muscle degeneration caused by Huntington’s disease
  • a revolutionary gamma camera to help diagnose and treat more cancers
  • a bio-engineered scaffold to repair injured tendons.

This follows 23 separate feasibility awards, totaling over $4.7 million, made earlier in 2014. It brings total investment via the Biomedical Catalyst to over $314 million since it was launched in 2012. It has leveraged a further $157 million in industry co-commitment and supported innovation from some 250 SME companies and universities.

Upcoming Events

  • 12Apr

    The Participant Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing